Products for Research Use Only
Hot

α-Bungarotoxin

CAT: 0804-HY-P1264Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P1264Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
α-Bungarotoxin is a competitive antagonist at nicotinic acetylcholine receptors (nAChRs) . α-Bungarotoxin, a selective α7 receptor blocker, blocks α7 currents with an IC50 of 1.6 nM and has no effects on α3β4 currents at concentrations up to 3 μM[1][2].
CAS Number
11032-79-4
UNSPSC
12352209
Hazard Statement
H302, H312, H332
Target
NAChR
Type
Peptides
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/α-bungarotoxin.html
Purity
99.0
Solubility
H2O : ≥ 50 mg/mL
Smiles
O=C(N[C@@H](C(C)C)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CC1=CC=C(C=C1)O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H](CCSC)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CO)C(N[C@@H](CO)C(N[C@@H](CCCNC(N)=N)C(NCC(N[C@@H](CCCCN)C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(NC4)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC5=O)C(N[C@@H](CC(O)=O)C(N[C@@H](C)C(N[C@H]5CC6=CC=CC=C6)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC7=O)C(N[C@@H](CC8=CNC=N8)C(N[C@@H]([C@H](O)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CO)C(N9[C@@H](CCC9)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CO)C(N[C@@H](C)C(N[C@@H](C(C)C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CSSC[C@@H](C(N[C@@H](C)C(N[C@@H](C)C(N[C@@H]([C@H](O)C)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CSSC[C@@H](C(N[C@@H](CC(N)=O)C(N%10[C@@H](CCC%10)C(N[C@@H](CC%11=CNC=N%11)C(N%12[C@@H](CCC%12)C(N[C@@H](CCCCN)C(N[C@@H](CCC(N)=O)C(N[C@@H](CCCNC(N)=N)C(N%13[C@@H](CCC%13)C(NCC(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC%14=O)C(N[C@@H](CO)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(O)=O)C(N[C@H]%14CCCCN)=O)=O)=O)=O)=O)NC%15=O)C(N%16[C@@H](CCC%16)C(N[C@@H](CO)C(N[C@@H](CCCCN)C(N[C@@H](CCCCN)C(N%17[C@@H](CCC%17)C(N[C@@H](CC%18=CC=C(C=C%18)O)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCC(O)=O)C(N[C@@H](C(C)C)C(N[C@H]%15[C@H](O)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC4=O)C(N%19[C@@H](CCC%19)C(N%20[C@@H](CCC%20)C(NCC(N[C@@H](CCC(O)=O)C(N[C@@H](CC(N)=O)C(N[C@H]7CC(C)C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H]([C@@H](C)CC)N
Molecular Formula
C338H529N97O105S11
Molecular Weight
7984.12
Precautions
H302, H312, H332
References & Citations
[1]Hannan S, et al. Snake neurotoxin α-bungarotoxin is an antagonist at native GABA (A) receptors. Neuropharmacology. 2015;93:28-40.|[2]López MG, et al. Unmasking the functions of the chromaffin cell alpha7 nicotinic receptor by using short pulses of acetylcholine and selective blockers. Proc Natl Acad Sci U S A. 1998;95 (24) :14184-14189.|[3]Balass M, et al. The alpha-bungarotoxin binding site on the nicotinic acetylcholine receptor: analysis using a phage-epitope library. Proc Natl Acad Sci U S A. 1997;94 (12) :6054-6058.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported